Equity Analysis

Quarterly Results

    ERIS Lifesciences Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    540596
    INE406M01024
    189.3277706
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ERIS
    171.63
    19972.84
    EPS(TTM)
    Face Value()
    Div & Yield %:
    8.55
    1
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales428.75449.17332.25
Other Operating Income7.817.529.05
Other Income 5.815.1620.39
Total Income442.37461.85361.69
Total Expenditure 293.93333.31261.91
PBIDT148.44128.5499.78
Interest 56.2656.1728.89
PBDT92.1872.3770.89
Depreciation46.1645.5529.14
Tax8.784.698.24
Fringe Benefit Tax0.000.000.00
Deferred Tax9.145.09-6.00
Reported Profit After Tax28.1017.0439.51
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item28.1017.0439.51
EPS (Unit Curr.)2.061.252.90
EPS (Adj) (Unit Curr.)2.061.252.90
Calculated EPS (Unit Curr.)2.061.252.90
Calculated EPS (Adj) (Unit Curr.)2.061.252.90
Calculated EPS (Ann.) (Unit Curr.)8.265.0111.61
Calculated EPS (Adj) (Ann.) (Unit Curr.)8.265.0111.61
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.6113.6113.61
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)34.6228.6230.03
PBDTM(%)21.5016.1121.34
PATM(%)6.553.7911.89
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.061.252.90